Effectiveness of rituximab in severe Wegener's granulomatosis: Report of two cases and review of the literature

Joaquim Oristrell, Guillermina Bejarano, Rosa Jordana, Manuel Monteagudo, Begoña Marí, Arnau Casanovas, Carles Tolosa

    Producció científica: Contribució a revistaArticle de revisióRecercaAvaluat per experts

    14 Cites (Scopus)

    Resum

    We hereby describe the satisfactory evolution of rituximab treatment in two patients with Wegener's granulomatosis (WG). Rituximab was indicated for refractoriness to standard treatment in one case and life-threatening myelotoxicity due to alkylating agents in the other. A brief review of previous experience with the use of rituximab in the treatment of WG is presented. © Oristrell et al.; Licensee Bentham Open.
    Idioma originalAnglès
    Pàgines (de-a)94-99
    RevistaOpen Respiratory Medicine Journal
    Volum3
    DOIs
    Estat de la publicacióPublicada - 1 de des. 2009

    Fingerprint

    Navegar pels temes de recerca de 'Effectiveness of rituximab in severe Wegener's granulomatosis: Report of two cases and review of the literature'. Junts formen un fingerprint únic.

    Com citar-ho